UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K/A
Amendment No. 2

(Mark One)

[X]         Amendment to Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2001

OR

[ ]         Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _______________ to _______________.

Commission File Number 1-11999

ALTERRA HEALTHCARE CORPORATION
(Exact Name of Registrant as Specified in its Charter)

DELAWARE
(State of Incorporation) 10000 Innovation Drive
Milwaukee, WI
(Address of Principal Executive Offices) 39-1771281
(I.R.S. Employer Identification No.)
  53226
(Zip Code)

(414) 918-5000
(Registrant's Telephone Number)

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:

TITLE OF EACH CLASS	NAME OF EXCHANGE ON WHICH REGISTERED
Common Stock, Par Value $.01 Per Share	American Stock Exchange
5.25% Convertible Subordinated Debenture Due 2002	American Stock Exchange
Series A Junior Preferred Stock Purchase Rights	American Stock Exchange

SECURITIES REGISTERED PURSUANT TO SECTION 12 (g) OF THE ACT:

NONE

         Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                  YES X NO

         Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendments to this Form 10-K. [ ]

         The aggregate market value of the voting stock held by non-affiliates of the Registrant was $3,110,684 as of March 29, 2002. The number of outstanding shares of the Registrant's Common Stock was 22,219,168 shares as of March 29, 2002.

EXPLANATORY NOTE

         This Report on Form 10-K/A amends and restates in its entirety the Signature Page of the Annual Report on Form 10-K of Alterra Healthcare Corporation (the "Company") for the fiscal year ended December 31, 2001 (inadvertently omitted from the initial filing of Form 10-K/A).

-2-

Pursuant to the requirements of the Securities Act of 1934, this report has been signed below by the following persons on behalf of registrant and in the capacities and on the dates indicated.

SIGNATURES	TITLE	DATE
/s/ Patrick F. Kennedy
Patrick F. Kennedy	President and Chief Executive Officer	March 29, 2002
/s/ Mark W. Ohlendorf	Senior Vice President, Chief Financial
Mark W. Ohlendorf	Officer, Treasurer and Secretary	March 29, 2002
	(Principal Financial Officer)
/s/ Kristin A. Ferge	Vice President and Assistant Secretary
Kristin A. Ferge	(Principal Accounting Officer)	March 29, 2002
/s/ Jerry L. Tubergen
Jerry L. Tubergen	Chairman of the Board and Director	April 1, 2002
/s/ Timothy J. Buchanan
Timothy J. Buchanan	Director	March 29, 2002
/s/ Gene E. Burleson
Gene E. Burleson	Director	March 29, 2002
/s/ William E. Colson
William E. Colson	Director	March 29, 2002
/s/ Ronald G. Geary
Ronald G. Geary	Director	March 29, 2002
/s/ Robert Haveman
Robert Haveman	Director	March 29, 2002
/s/ William G. Petty, Jr.
William G. Petty, Jr.	Director	March 29, 2002
/s/ Natalie Townsend
Natalie Townsend	Director	March 29, 2002

-3-

SIGNATURE

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this Amendment to be signed on its behalf by the undersigned, thereunto duly authorized.

                                                      ALTERRA HEALTHCARE CORPORATION.

By:   /s/Kristin A. Ferge
Kristin A. Ferge
Vice President, Assistant Secretary

Dated: April 1, 2002